U.S. employers unexpectedly cut more jobs in September than in August, underscoring the fragility of the economy's recovery from its worst recession in 70 years as businesses remain cautious about the future.
The U.S. Senate Finance Committee on Friday wrapped up debate on a massive overhaul of the U.S. healthcare system and prepared to vote on the legislation next week.
A dearth of new products, new technologies and fresh commitments by governments scrambling to protect their populations from pandemic threats have lured U.S. drugmakers back into the flu vaccine business.
U.S. News & World Report released its picks in its October issue for the best affordable places to retire.
U.S. President Barack Obama announced a plan on Wednesday to spend $5 billion to create new jobs for medical and scientific research, medical supplies and improved laboratory capacity.
The Canadian province of Ontario said on Tuesday it has filed a lawsuit seeking C$50 billion ($45.9 billion) in damages from tobacco companies for healthcare costs incurred by taxpayers since 1955.
Most Americans would pay higher taxes to fund healthcare reforms that provide the best quality of care, but only a minority expects Washington to deliver it, according to a survey released on Wednesday.
A Senate panel on Tuesday rejected a government-run public insurance option as part of a broad healthcare overhaul, handing insurers an early victory and setting the stage for a long fight over one of the bill's most contentious issues.
Canada outperforms the United States in health outcomes but is well behind global leaders like Japan in overall health of its population, a Canadian report released on Monday showed.
The world's two largest diversified healthcare companies struck deals on Monday that will propel them into vaccines, a red-hot area for investors because of the pandemic flu threat and potential high profits for preventing other diseases.
U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday, aimed at securing vaccines and other products key to future growth.
After his efforts at diplomacy on the international stage last week, President Barack Obama faces some particularly daunting foreign policy decisions about the Afghan war, a nuclear Iran and an elusive Middle East peace.
Just like the government's cash for clunkers program, investors are ready to cash in junk stock holdings for sounder equities, analysts say.
U.S. diversified health care company Johnson & Johnson has bought an 18 percent stake in biotech firm Crucell for 302 million euros ($444 million) as part of a flu vaccine development deal, the Dutch company said on Monday.
U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday aimed at securing vaccines and other products key to future growth.
U.S. drugmaker Abbott Laboratories plans to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros), two sources familiar with the situation said on Sunday, with an announcement expected on Monday.
U.S. drugmaker Abbott Laboratories plans to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros), two sources familiar with the situation said on Sunday, with an announcement expected on Monday.
U.S. drugmaker Abbott Laboratories is planning to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros) in cash, with an announcement expected in the next 24 hours, a source familiar with the situation said on Sunday.
Australia's health system is failing the many people who suffer from multiple illnesses as it is principally designed to deal with individual conditions, a new study suggests.
Paul Kirk, a former Democratic National Committee chairman and a close friend of the late Senator Edward Kennedy, was named on Thursday as a temporary replacement for the liberal champion in the U.S. Senate.
The secret to fixing healthcare in the United States is to focus on value, a measure that takes into account both quality and cost, says Dr. Denis Cortese, president of the Mayo Clinic.
The Senate Finance Committee battled over insurance plans for seniors on Wednesday and rejected a Republican effort to delay a final vote on a broad healthcare overhaul as it slowly waded through a crush of amendments.
